Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampy

manouli · 04-02-2012, 10:07 AM

Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) of Walking Problems in Patients with Multiple Sclerosis

New site – www.AmpyraJourneys.com – is first to focus exclusively on walking problems for people living with MS, with patient profiles, medical information, and opportunities for visitors to post messages of inspiration to help others.

HAWTHORNE, N.Y.--(BUSINESS WIRE)--

Acorda Therapeutics, Inc. (Nasdaq: ACOR - News) today announced the launch of a new interactive patient website called Ampyra Journeys (www.AmpyraJourneys.com). The site is the first-ever stand-alone patient site to focus on walking problems associated with multiple sclerosis (MS). Ampyra (dalfampridine) is an oral medication approved by the FDA as a treatment to improve walking in patients with multiple sclerosis. This was demonstrated by an increase in walking speed.

more...

http://finance.yahoo.com/news/acorda...120000359.html

04-02-2012, 10:07 AM	#1
manouli Senior Member Join Date: Nov 2004 Location: florida Posts: 9,339	Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampy Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) of Walking Problems in Patients with Multiple Sclerosis New site – www.AmpyraJourneys.com – is first to focus exclusively on walking problems for people living with MS, with patient profiles, medical information, and opportunities for visitors to post messages of inspiration to help others. HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR - News) today announced the launch of a new interactive patient website called Ampyra Journeys (www.AmpyraJourneys.com). The site is the first-ever stand-alone patient site to focus on walking problems associated with multiple sclerosis (MS). Ampyra (dalfampridine) is an oral medication approved by the FDA as a treatment to improve walking in patients with multiple sclerosis. This was demonstrated by an increase in walking speed. more... http://finance.yahoo.com/news/acorda...120000359.html

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Inju	manouli	Cure	3	07-01-2011 10:28 PM
Acorda Therapeutics Launches ZANAFLEX CAPSULES for the Management of Spasticity in People	Jeremy	Cure	0	04-04-2005 07:33 AM
BW)(NY-ACORDA) Acorda Therapeutics Completes $55 Million Private Financing Led By Easton Hunt Capital Partners, L.P.	Max	Funding, Legislation, & Advocacy	2	05-13-2003 10:10 AM
BW)(NY-ACORDA-THERAPEUTICS) Acorda Therapeutics to Present at the SG Cowen 23rd Annual Healthcare Conference	Max	Cure	0	03-19-2003 11:34 AM
Acorda Therapeutics	Birde	Web Links	0	07-29-2001 07:48 PM